Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia
British Journal of Haematology · 2023
DOI: 10.1111/bjh.18802 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Phillip C Nguyen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Undetectable measurable residual disease (MRD) is associated with favourable clinical outcomes in chronic lymphocytic leukaemia (CLL). While assessment is commonly performed using multiparameter flow cytometry (MFC), this approach is associated with limitations including user bias and expertise that may not be widely available. Implementation of unsupervised clustering algorithms in the laboratory can address these limitations and have not been previously reported in a systematic quantitative manner. We developed a computational pipeline to assess CLL MRD using FlowSOM. In the training step, a self‐organising map was generated with nodes representing the full breadth of normal immature and mature B cells along with disease immunophenotypes. This map was used to detect MRD in multiple validation cohorts containing a total of 456 samples. This included an evaluation of atypical CLL cases and samples collected from two different laboratories. Computational MRD showed high correlation with expert analysis (Pearson's r > 0.99 for typical CLL). Binary classification of typical CLL samples as either MRD positive or negative demonstrated high concordance (>98%). Interestingly, computational MRD detected disease in a small number of atypical CLL cases in which MRD was not detected by expert analysis. These results demonstrate the feasibility and value of automated MFC analysis in a diagnostic laboratory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
- Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Phillip C Nguyen, Piers Blombery
Zitieren
APA
Nguyen, P. C., Nguyen, V., Baldwin, K., Kankanige, Y., Blombery, P., Came, N., & Westerman, D. A. (2023). Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.18802
Vancouver
Nguyen PC, Nguyen V, Baldwin K, Kankanige Y, Blombery P, Came N, et al. Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia. British Journal of Haematology. 2023. doi:10.1111/bjh.18802
BibTeX
@article{Nguyen2023,
author = {Nguyen, Phillip C and Nguyen, Vuong and Baldwin, Kylie and Kankanige, Yamuna and Blombery, Piers and Came, Neil and Westerman, David A},
title = {Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.18802}
}
EUVIMED